Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Feb 12;18(3):378-81.
doi: 10.1038/nm.2658.

RET, ROS1 and ALK fusions in lung cancer

Kengo Takeuchi  1 , Manabu Soda, Yuki Togashi, Ritsuro Suzuki, Seiji Sakata, Satoko Hatano, Reimi Asaka, Wakako Hamanaka, Hironori Ninomiya, Hirofumi Uehara, Young Lim Choi, Yukitoshi Satoh, Sakae Okumura, Ken Nakagawa, Hiroyuki Mano, Yuichi Ishikawa
Affiliations

RET, ROS1 and ALK fusions in lung cancer

Kengo Takeuchi et al. Nat Med. .

Abstract

Through an integrated molecular- and histopathology-based screening system, we performed a screening for fusions of anaplastic lymphoma kinase (ALK) and c-ros oncogene 1, receptor tyrosine kinase (ROS1) in 1,529 lung cancers and identified 44 ALK-fusion-positive and 13 ROS1-fusion-positive adenocarcinomas, including for unidentified fusion partners for ROS1. In addition, we discovered previously unidentified kinase fusions that may be promising for molecular-targeted therapy, kinesin family member 5B (KIF5B)-ret proto-oncogene (RET) and coiled-coil domain containing 6 (CCDC6)-RET, in 14 adenocarcinomas. A multivariate analysis of 1,116 adenocarcinomas containing these 71 kinase-fusion-positive adenocarcinomas identified four independent factors that are indicators of poor prognosis: age ≥ 50 years, male sex, high pathological stage and negative kinase-fusion status.

PubMed Disclaimer

Comment in

  • Genetics: Gene fusion power.
    Villanueva MT. Villanueva MT. Nat Rev Clin Oncol. 2012 Feb 28;9(4):188. doi: 10.1038/nrclinonc.2012.26. Nat Rev Clin Oncol. 2012. PMID: 22371133 No abstract available.
  • Chipping away at the lung cancer genome.
    Pao W, Hutchinson KE. Pao W, et al. Nat Med. 2012 Mar 6;18(3):349-51. doi: 10.1038/nm.2697. Nat Med. 2012. PMID: 22395697 No abstract available.

References

    1. Cell. 2007 Dec 14;131(6):1190-203 - PubMed
    1. Cancer Res. 2008 Sep 15;68(18):7629-37 - PubMed
    1. Cell. 1990 Feb 23;60(4):557-63 - PubMed
    1. Haematologica. 2011 Mar;96(3):464-7 - PubMed
    1. Clin Cancer Res. 2011 May 15;17(10):3341-8 - PubMed

Publication types

MeSH terms